Amy S. Langer

8.5k total citations · 1 hit paper
8 papers, 859 citations indexed

About

Amy S. Langer is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Amy S. Langer has authored 8 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cancer Research, 2 papers in Oncology and 2 papers in Genetics. Recurrent topics in Amy S. Langer's work include Breast Cancer Treatment Studies (3 papers), Estrogen and related hormone effects (2 papers) and BRCA gene mutations in cancer (2 papers). Amy S. Langer is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), Estrogen and related hormone effects (2 papers) and BRCA gene mutations in cancer (2 papers). Amy S. Langer collaborates with scholars based in United States. Amy S. Langer's co-authors include Timothy J. Whelan, Clifford A. Hudis, Stephen B. Edge, David G. Pfister, Jeffrey J. Kirshner, Lawrence J. Solin, George W. Sledge, Gini F. Fleming, Alison Estabrook and Robert R. Kuske and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Investigation.

In The Last Decade

Amy S. Langer

7 papers receiving 818 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*

2001 616 citations Abram Recht, Stephen B. Edge et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Amy S. Langer

Since Specialization

Citations

This map shows the geographic impact of Amy S. Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy S. Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy S. Langer more than expected).

Fields of papers citing papers by Amy S. Langer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy S. Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy S. Langer. The network helps show where Amy S. Langer may publish in the future.

Co-authorship network of co-authors of Amy S. Langer

This figure shows the co-authorship network connecting the top 25 collaborators of Amy S. Langer. A scholar is included among the top collaborators of Amy S. Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy S. Langer. Amy S. Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Breast Cancer? Let Me Check My Schedule! 2019 ·(unknown), Donna Cederberg, (unknown), (unknown), (unknown), (unknown), Amy S. Langer, (unknown), (unknown), (unknown), (unknown)	0
2	American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting 2003 ·Journal of Clinical Oncology ·Eric P. Winer, Clifford A. Hudis, Harold J. Burstein, John Bryant, Rowan T. Chlebowski, James N. Ingle, Stephen B. Edge, Eleftherios P. Mamounas, Richard D. Gelber, Julie R. Gralow, Lori J. Goldstein, Kathleen I. Pritchard, Susan Braun, Melody Cobleigh, Amy S. Langer, (unknown), Trevor J. Powles, Timothy J. Whelan, George P. Browman	58
3	American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002 2002 ·Journal of Clinical Oncology ·Eric P. Winer, Clifford A. Hudis, Harold J. Burstein, Rowan T. Chlebowski, James N. Ingle, Stephen B. Edge, Eleftherios P. Mamounas, Julie R. Gralow, Lori J. Goldstein, Kathleen I. Pritchard, Susan Braun, Melody Cobleigh, Amy S. Langer, (unknown), Trevor J. Powles, Timothy J. Whelan, George P. Browman	163
4	Side Effects, Quality-of-Life Issues, and Trade-offs: the Patient Perspective 2001 ·JNCI Monographs ·Amy S. Langer	13
5	Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology* breakdown → 2001 ·Journal of Clinical Oncology ·Abram Recht, Stephen B. Edge, Lawrence J. Solin, David S. Robinson, Alison Estabrook, Richard E. Fine, Gini F. Fleming, Silvia C. Formenti, Clifford A. Hudis, Jeffrey J. Kirshner, David A. Krause, Robert R. Kuske, Amy S. Langer, George W. Sledge, Timothy J. Whelan, David G. Pfister	616
6	Workgroup V 1998 ·Cancer ·(unknown), (unknown), (unknown), (unknown), Heather T. Gold, Amy S. Langer, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
7	The Role of Advocacy in Cancer Research: Not a Monster 1997 ·Cancer Investigation ·Amy S. Langer	3
8	The politics of breast cancer. 1993 ·PubMed ·Amy S. Langer	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact